Free service for Cre mice and cryopreservation! Cooperation for 2019 subsidy application.
We will provide free services for Cre mice and cryopreservation for up to 3 years upon ordering the 300 lines of cKO created by TurboKnockout. Our company, Saiyagen, offers gene targeting strategies as a free service, ensuring high reliability for your research, provided at a reasonable budget, and has successfully collaborated on numerous applications for scientific research funding. 【Service Overview】 <Conditional Knockout Mice> ■ Production Period: 6 to 8 months ■ Deliverables: 3 F1 mice ■ Offered at a promotional price *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【About the Campaign】 ■Period: From April 1 to June 30 ■Target: Customers in Japan ■Free Shipping: Free delivery to customers' animal facilities *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
In 2005, we were established as a contract research organization for pharmaceutical development and a manufacturer of cell-related products. Currently, we have 400 employees worldwide. Our headquarters is located in Silicon Valley, California, USA, with manufacturing bases in Suzhou and Guangzhou, China. In 2016, we opened a branch in Tokyo, Japan. As a leading company in the production of genetically modified animal models, we provide high-quality reagents and tools at reasonable prices. 1. Production of genetically modified animal models: As a leading company in the contract production of rodent animal models, we offer a one-stop service that is optimal for research. Our services cover a wide range, including vector construction, ES cell manipulation, and microinjection production, allowing us to accept contracts for animal model production at any stage of the process. We are also engaged in contract services for animal models using the CRISPR-Cas9 system and artificial nuclease technology. The artificial nuclease technology can save time and costs compared to traditional gene targeting techniques.